These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 35830716)

  • 1. OSU-T315 and doxorubicin synergistically induce apoptosis via mitochondrial pathway in bladder cancer cells.
    Li Z; Ren D; Chen C; Sun L; Fang K
    Cell Biol Int; 2022 Oct; 46(10):1672-1681. PubMed ID: 35830716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Novel Small Molecule Inhibitor, OSU-T315, Suppresses Vestibular Schwannoma and Meningioma Growth by Inhibiting PDK2 Function in the AKT Pathway Activation.
    Mercado-Pimentel ME; Igarashi S; Dunn AM; Behbahani M; Miller C; Read CM; Jacob A
    Austin J Med Oncol; 2016; 3(1):. PubMed ID: 27642646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput screening identifies stevioside as a potent agent to induce apoptosis in bladder cancer cells.
    Chen C; Na X; Wang L; Yu R
    Biochem Pharmacol; 2022 Sep; 203():115166. PubMed ID: 35820501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cells.
    Liu TM; Ling Y; Woyach JA; Beckwith K; Yeh YY; Hertlein E; Zhang X; Lehman A; Awan F; Jones JA; Andritsos LA; Maddocks K; MacMurray J; Salunke SB; Chen CS; Phelps MA; Byrd JC; Johnson AJ
    Blood; 2015 Jan; 125(2):284-95. PubMed ID: 25293770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific Therapeutics.
    Van Belle K; Herman J; Waer M; Sprangers B; Louat T
    J Immunol Res; 2018; 2018():2505818. PubMed ID: 30276218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OSU-03012, a non-Cox inhibiting celecoxib derivative, induces apoptosis of human esophageal carcinoma cells through a p53/Bax/cytochrome c/caspase-9-dependent pathway.
    Liu J; Qin CK; Lv W; Zhao Q; Qin CY
    Anticancer Drugs; 2013 Aug; 24(7):690-8. PubMed ID: 23652278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced apoptotic effects by downregulating Mcl-1: evidence for the improvement of photodynamic therapy with Celecoxib.
    Song J; Chen Q; Xing D
    Exp Cell Res; 2013 Jun; 319(10):1491-504. PubMed ID: 23524145
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Yang J; Jiang X; Chen Y; Teng L
    Discov Med; 2023 Dec; 35(179):1167-1176. PubMed ID: 38058082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T315 Decreases Acute Myeloid Leukemia Cell Viability through a Combination of Apoptosis Induction and Autophagic Cell Death.
    Chiu CF; Weng JR; Jadhav A; Wu CY; Sargeant AM; Bai LY
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ipatasertib (GDC-0068) and erdafitinib co-treatment for inducing mitochondrial apoptosis through Bim upregulation in bladder cancer cells.
    Hu C; Shang X; Zheng T; Hu X; Zhao Y
    Biochem Biophys Res Commun; 2022 May; 604():165-171. PubMed ID: 35306249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
    Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
    Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptotanshinone Ameliorates Doxorubicin-Induced Cardiotoxicity by Targeting Akt-GSK-3β-mPTP Pathway In Vitro.
    Wang X; Sun Q; Jiang Q; Jiang Y; Zhang Y; Cao J; Lu L; Li C; Wei P; Wang Q; Wang Y
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33800264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of Mcl-1 through GSK-3β Activation Regulates Apoptosis Induced by Bufalin in Non-Small Cell Lung Cancer H1975 Cells.
    Kang XH; Zhang JH; Zhang QQ; Cui YH; Wang Y; Kou WZ; Miao ZH; Lu P; Wang LF; Xu ZY; Cao F
    Cell Physiol Biochem; 2017; 41(5):2067-2076. PubMed ID: 28419994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro.
    Smolensky D; Rathore K; Cekanova M
    BMC Cancer; 2015 Nov; 15():927. PubMed ID: 26597249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity.
    Jing X; Yang J; Jiang L; Chen J; Wang H
    Cell Physiol Biochem; 2018; 48(2):692-704. PubMed ID: 30025410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VCPA, a novel synthetic derivative of α-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunction.
    Wu H; Liu S; Gong J; Liu J; Zhang Q; Leng X; Zhang N; Li Y
    Cancer Lett; 2017 May; 393():22-32. PubMed ID: 28216375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.
    Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
    Leukemia; 2013 Feb; 27(2):315-24. PubMed ID: 22751450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OSU-03012, a novel celecoxib derivative, is cytotoxic to myeloma cells and acts through multiple mechanisms.
    Zhang S; Suvannasankha A; Crean CD; White VL; Johnson A; Chen CS; Farag SS
    Clin Cancer Res; 2007 Aug; 13(16):4750-8. PubMed ID: 17699852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.
    Rahmani M; Aust MM; Attkisson E; Williams DC; Ferreira-Gonzalez A; Grant S
    Cancer Res; 2013 Feb; 73(4):1340-51. PubMed ID: 23243017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death.
    Venkatesan B; Prabhu SD; Venkatachalam K; Mummidi S; Valente AJ; Clark RA; Delafontaine P; Chandrasekar B
    Cell Signal; 2010 May; 22(5):809-20. PubMed ID: 20074638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.